New gadget aims to take the guesswork out of measuring skin hardening in scleroderma
NCT ID NCT07543679
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study is testing a new device called ADHELASKIN to see if it can measure skin stiffness more accurately than the current method (feeling the skin by hand) in people with systemic sclerosis (scleroderma). The study will compare 100 participants: those with scleroderma and healthy volunteers. The goal is to find a more objective and reliable way to track skin damage, which could improve how doctors monitor the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for D013493 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Saint-Etienne
RECRUITINGSaint-Priest-en-Jarez, Pays de la Loire Region, 42270, France